DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2030
Anti-pollution Mask Market Report Highlights
The global anti-pollution mask market size is expected to reach USD 63.32 billion by 2030, expanding at a CAGR of 38.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as rising awareness for remedial measures to combat increased pollution levels and high rate of adoption of healthy lifestyle are expected to remain the prominent trends in the market.
The recent outbreak of COVID-19 pandemic is expected to drive the demand for anti-pollution masks during the forecast period. According to a report by Cable News Network, 3M Company has been witnessing an unprecedented spike in the demand for N95 respirator masks since the beginning of 2020 across the globe. Shortage of protection masks in maximum offline stores as well as major e-commerce platforms has led to manufacturers ramping up their production capacity and distribution channels, which is one of the key attributes driving the market growth.
The growing urbanization and industrialization particularly in developing regions such as India and China plays a predominant role in increasing the pollution level. In addition, increasing number of vehicles adds to further degradation of air quality. These factors play a major role in driving the demand for anti-pollution masks in the market. Anti-pollution masks are available in different standard ratings such as N95, N99, N100, P95, and P100, as recommended by NIOSH, an association of U.S. Centers for Disease Control and Prevention.
The P rated masks are resistant to oil based particles and are used for working at places exposed to oil whereas, N rated ones are not resistant to oil based pollutants. N95 filters up to 95% of the Particulate Matter 2.5 (PM2.5) while, N99 masks filter up to 99% of PM2.5 owing to the higher rate of filtration.
Asia Pacific region is expected to witness the largest as well as fastest growth owing to rapid industrialization and development in automobile sector. The rapidly growing population in developing economies such as India and China is leading to rapid urbanization, which is increasing the pollutant levels in the atmosphere, thus boosting the product demand. According to a report by Institute for Health Metrics and Evaluation, 5.5 people die every year on account of indoor and outdoor air pollution.
The prominent players in the anti-pollution mask market are focusing on product innovation. For instance, in November 2016, Xiaomi launched battery powered anti-pollution mask to filter out PM2.5 particles from breathing. It is manufactured with hand-woven polyester material and equipped with battery powered nano filter, which is chargeable through a USB port. Furthermore, in November 2018, O2TODAY launched urban face mask, O2SafeAir through global travel retail Indiegogo. It is expected to be highly breathable, machine washable and engages with interchangeable filters from protection against pollution and microorganisms.
Anti-pollution Mask Market Report Highlights
- The disposable masks segment dominated the global anti-pollution mask market with a revenue share of 53.4% in 2024.
- The reusable masks segment is projected to experience the highest CAGR from 2025 to 2030.
- The offline distribution segment held the largest revenue share of the global anti-pollution mask market in 2024.
- The online distribution segment is anticipated to experience the highest CAGR from 2025 to 2030.
- Asia Pacific dominated the global anti-pollution mask market with a revenue share of 34.1% in 2024.
- Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment scope
- 1.1.2 Regional scope
- 1.1.3 Estimates and forecast timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased database:
- 1.3.2 GVR’s internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
- 1.4 Information or Data Analysis
- 1.4.1 Data analysis models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach: Commodity Flow Approach
- 1.7 Research Assumptions
- 1.8 List of Secondary Sources
- 1.9 List of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
- Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
- Chapter 3 DNA Microarray Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market
- 3.2 Market Dynamics
- 3.2.1 Market drivers analysis
- 3.2.1.1 Increasing adoption of DNA microarray for various applications
- 3.2.1.2 Increasing prevalence of genetic disorders and cancers
- 3.2.1.3 Growing research activities
- 3.2.2 Market restraint analysis
- 3.2.2.1 High cost involved in the sequencing
- 3.2.2.2 Availability of cost effetive alternative
- 3.3 Penetration & Growth Prospect Mapping
- 3.4 DNA Microarray: Market Analysis Tools
- 3.4.1 Industry analysis - Porter’s
- 3.4.2 PESTLE analysis
- 3.5 Regulatory Framework
- Chapter 4 DNA Microarray Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1 Definition and Scope
- 4.2 Type Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Global DNA Microarray Market, by Type, 2018 to 2030
- 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 4.5.1 Complementary DNA microarrays
- 4.5.1.1 Complementary DNA microarraysmarket estimates and forecast, 2018 - 2030 (USD Million)
- 4.5.2 Oligonucleotide DNA microarrays
- 4.5.2.1 Oligonucleotide DNA microarraysmarket estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 5 DNA Microarray Market Segment Analysis, By Application 2018 - 2030 (USD Million)
- 5.1 Definition and Scope
- 5.2 Application Market Share Analysis, 2022 & 2030
- 5.3 Segment Dashboard
- 5.4 Global DNA Microarray Market, by Application, 2018 to 2030
- 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 5.5.1 Gene expression analysis
- 5.5.1.1 Gene expression analysis market estimates and forecast, 2018 - 2030, (USD Million)
- 5.5.2 Genotyping
- 5.5.2.1 Genotyping market estimates and forecast, 2018 - 2030, (USD Million)
- 5.5.3 Others
- 5.5.5.1 Others estimates and forecast, 2018 - 2030, (USD Million)
- Chapter 6 DNA Microarray Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 6.1 Definition and Scope
- 6.2 End Use Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 Global DNA Microarray Market, by End Use, 2018 to 2030
- 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 6.5.1 Pharmaceutical and biotechnology companies
- 6.5.1.1 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.2 Diagnostic centers
- 6.5.2.1 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3 Hospitals and clinics
- 6.5.3.1 Hospitals and clinics market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3 Academic and research institute
- 6.5.3.1 Academic and research institute market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3 Others
- 6.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 7 DNA Microarray Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
- 7.1 Definition & Scope
- 7.2 Regional Market Share Analysis, 2022 & 2030
- 7.3 Regional Market Dashboard
- 7.4 Regional Market Snapshot
- 7.5 SWOT Analysis
- 7.5.1 North America
- 7.5.2 Europe
- 7.5.3 Asia Pacific
- 7.5.4 Latin America
- 7.5.5 Middle East & Africa
- 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
- 7.6.1 North America
- 7.6.1.1 North America DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.1.2 U.S.
- 7.6.1.2.1 Key Country Dynamics
- 7.6.1.2.2 Competitive Scenario
- 7.6.1.2.3 Regulatory Framework
- 7.6.1.2.4 Reimbursement Scenario
- 7.6.1.2.5 U.S. DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.1.3 Canada
- 7.6.1.3.1 Key Country Dynamics
- 7.6.1.3.2 Competitive Scenario
- 7.6.1.3.3 Regulatory Framework
- 7.6.1.3.4 Reimbursement Scenario
- 7.6.1.3.5 Canada DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.1.4 Mexico
- 7.6.1.4.1 Key Country Dynamics
- 7.6.1.4.2 Competitive Scenario
- 7.6.1.4.3 Regulatory Framework
- 7.6.1.4.4 Reimbursement Scenario
- 7.6.1.4.5 Mexico DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2 Europe
- 7.6.2.1 Europe DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.2 UK
- 7.6.2.2.1 Key Country Dynamics
- 7.6.2.2.2 Competitive Scenario
- 7.6.2.2.3 Regulatory Framework
- 7.6.2.2.4 Reimbursement Scenario
- 7.6.2.2.5 UK DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.3 Germany
- 7.6.2.3.1 Key Country Dynamics
- 7.6.2.3.2 Competitive Scenario
- 7.6.2.3.3 Regulatory Framework
- 7.6.2.23.4 Reimbursement Scenario
- 7.6.2.3.5 Germany DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.4 Spain
- 7.6.2.4.1 Key Country Dynamics
- 7.6.2.4.2 Competitive Scenario
- 7.6.2.4.3 Regulatory Framework
- 7.6.2.4.4 Reimbursement Scenario
- 7.6.2.4.5 Spain DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.5 France
- 7.6.2.5.1 Key Country Dynamics
- 7.6.2.5.2 Competitive Scenario
- 7.6.2.5.3 Regulatory Framework
- 7.6.2.5.4 Reimbursement Scenario
- 7.6.2.5.5 France DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.6 Italy
- 7.6.2.6.1 Key Country Dynamics
- 7.6.2.6.2 Competitive Scenario
- 7.6.2.6.3 Regulatory Framework
- 7.6.2.6.4 Reimbursement Scenario
- 7.6.2.6.5 Italy DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.7 Denmark
- 7.6.2.7.1 Key Country Dynamics
- 7.6.2.7.2 Competitive Scenario
- 7.6.2.7.3 Regulatory Framework
- 7.6.2.7.4 Reimbursement Scenario
- 7.6.2.7.5 Denmark DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.8 Sweden
- 7.6.2.8.1 Key Country Dynamics
- 7.6.2.8.2 Competitive Scenario
- 7.6.2.8.3 Regulatory Framework
- 7.6.2.8.4 Reimbursement Scenario
- 7.6.2.8.5 Sweden DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2.9 Norway
- 7.6.2.9.1 Key Country Dynamics
- 7.6.2.9.2 Competitive Scenario
- 7.6.2.9.3 Regulatory Framework
- 7.6.2.9.4 Reimbursement Scenario
- 7.6.2.9.5 Norway DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3 Asia Pacific
- 7.6.3.1 Asia Pacific DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3.2 Japan
- 7.6.3.2.1 Key Country Dynamics
- 7.6.3.2.2 Competitive Scenario
- 7.6.3.2.3 Regulatory Framework
- 7.6.3.2.4 Reimbursement Scenario
- 7.6.3.2.5 Japan DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3.3 China
- 7.6.3.3.1 Key Country Dynamics
- 7.6.3.3.2 Competitive Scenario
- 7.6.3.3.3 Regulatory Framework
- 7.6.3.3.4 Reimbursement Scenario
- 7.6.3.3.5 China DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3.4 India
- 7.6.3.4.1 Key Country Dynamics
- 7.6.3.4.2 Competitive Scenario
- 7.6.3.4.3 Regulatory Framework
- 7.6.3.4.4 Reimbursement Scenario
- 7.6.3.4.5 India DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3.5 South Korea
- 7.6.3.5.1 Key Country Dynamics
- 7.6.3.5.2 Competitive Scenario
- 7.6.3.5.3 Regulatory Framework
- 7.6.3.5.4 Reimbursement Scenario
- 7.6.3.5.5 South Korea DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3.6 Australia
- 7.6.3.6.1 Key Country Dynamics
- 7.6.3.6.2 Competitive Scenario
- 7.6.3.6.3 Regulatory Framework
- 7.6.3.6.4 Reimbursement Scenario
- 7.6.3.6.5 Australia DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3.7 Thailand
- 7.6.3.7.1 Key Country Dynamics
- 7.6.3.7.2 Competitive Scenario
- 7.6.3.7.3 Regulatory Framework
- 7.6.3.7.4 Reimbursement Scenario
- 7.6.3.7.5 Thailand DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.4 Latin America
- 7.6.4.1 Latin America DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.4.2 Brazil
- 7.6.4.2.1 Key Country Dynamics
- 7.6.4.2.2 Competitive Scenario
- 7.6.4.2.3 Regulatory Framework
- 7.6.4.2.4 Reimbursement Scenario
- 7.6.4.2.5 Brazil DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.4.4 Argentina
- 7.6.4.4.1 Key Country Dynamics
- 7.6.4.4.2 Competitive Scenario
- 7.6.4.4.3 Regulatory Framework
- 7.6.4.4.4 Reimbursement Scenario
- 7.6.4.4.5 Argentina DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5 MEA
- 7.6.5.1 MEA DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5.2 South Africa
- 7.6.5.2.1 Key Country Dynamics
- 7.6.5.2.2 Competitive Scenario
- 7.6.5.2.3 Regulatory Framework
- 7.6.5.2.4 Reimbursement Scenario
- 7.6.5.2.5 South Africa DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5.3 Saudi Arabia
- 7.6.5.3.1 Key Country Dynamics
- 7.6.5.3.2 Competitive Scenario
- 7.6.5.3.3 Regulatory Framework
- 7.6.5.3.4 Reimbursement Scenario
- 7.6.5.3.5 Saudi Arabia DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5.4 UAE
- 7.6.5.4.1 Key Country Dynamics
- 7.6.5.4.2 Competitive Scenario
- 7.6.5.4.3 Regulatory Framework
- 7.6.5.4.4 Reimbursement Scenario
- 7.6.5.4.5 UAE DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5.5 Kuwait
- 7.6.5.5.1 Key Country Dynamics
- 7.6.5.5.2 Competitive Scenario
- 7.6.5.5.3 Regulatory Framework
- 7.6.5.5.4 Reimbursement Scenario
- 7.6.5.5.5 Kuwait DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 8 DNA Microarray Market - Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.1.1 Ansoff matrix
- 8.1.2 Heat map analysis
- 8.1.3 Major Deals and Strategic Alliances Analysis
- 8.1.3.1 Joint Ventures
- 8.1.3.2 Licensing Agreements
- 8.1.3.3 Product Launches
- 8.1.3.1 Conferences and Campaigns
- 8.2 Company Categorization
- 8.2.1 Innovators
- 8.2.2 Market Leaders
- 8.3 Vendor Landscape
- 8.3.1 List of key distributors and channel partners
- 8.3.2 Key customers
- 8.4 Public Companies
- 8.4.1 Competitive Dashboard Analysis
- 8.4.1.1 Market Differentiators
- 8.5 Private Companies
- 8.5.1 List of key emerging companies
- 8.6 Company Profiles
- 8.6.1 QIAGEN
- 8.6.1.1 Company overview
- 8.6.1.2 Financial performance
- 8.6.1.3 Product benchmarking
- 8.6.1.4 Strategic Initiatives
- 8.6.2 Illumina, Inc.
- 8.6.2.1 Company overview
- 8.6.2.2 Financial performance
- 8.6.2.3 Product benchmarking
- 8.6.2.4 Strategic Initiatives
- 8.6.3 Merck KGaA
- 8.6.3.1 Company overview
- 8.6.3.2 Financial performance
- 8.6.3.3 Product benchmarking
- 8.6.3.4 Strategic Initiatives
- 8.6.4 Thermo Fisher Scientific, Inc.
- 8.6.4.1 Company overview
- 8.6.4.2 Financial performance
- 8.6.4.3 Product benchmarking
- 8.6.4.4 Strategic Initiatives
- 8.6.5 BIOMERIEUX
- 8.6.5.1 Company overview
- 8.6.5.2 Financial performance
- 8.6.5.3 Product benchmarking
- 8.6.5.4 Strategic Initiatives
- 8.6.6 Agilent Technologies, Inc.
- 8.6.6.1 Company overview
- 8.6.6.2 Financial performance
- 8.6.6.3 Product benchmarking
- 8.6.6.4 Strategic Initiatives
- 8.6.7 F. Hoffmann-La Roche Ltd.
- 8.6.7.1 Company overview
- 8.6.7.2 Financial performance
- 8.6.7.3 Product benchmarking
- 8.6.7.4 Strategic initiatives
- 8.6.8 PerkinElmer, Inc.
- 8.6.8.1 Company overview
- 8.6.8.2 Financial performance
- 8.6.8.3 Product benchmarking
- 8.6.8.4 Strategic initiatives
- 8.6.9 Applied Micro Arrays
- 8.6.9.1 Company overview
- 8.6.9.2 Financial performance
- 8.6.9.3 Product benchmarking
- 8.6.9.4 Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook